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Abstract 
OBJECTIVES 
This study was conducted to clarify the relationship between body mass index and mitral 
valve (MV) surgery and to determine whether an ‘obesity paradox’ exists in the context of 
surgery for degenerative MV disease. 
METHODS 
In this retrospective single-centre study, we analysed data from 715 patients who underwent 
mitral surgery for degenerative disease from 2000 to 2015. Patients were classified according 
to body mass index: underweight (<20 kg/m2), normal weight (20–24.99 kg/m2), overweight 
(25–29.99 kg/m2) and obese (≥30 kg/m2). Early and long-term results were investigated. 
Multivariable analysis was conducted to identify risk factors for long-term mortality. 
RESULTS 
Mean follow-up was 67 ± 44 months (range 0–190 months). There were no differences 
between groups regarding 30-day mortality (P = 0.35), stroke (P = 0.45), reoperation for 
bleeding (P = 0.9) and length of hospital stay (P = 0.31). Obese patients were at increased risk 
of acute kidney injury when compared with normal weight patients (17% vs 5%; P = 0.03) 
but not when compared with the other groups; this was confirmed within the subgroup with 
depressed ejection fraction (42% vs 10%, P = 0.02). No differences in long-term survival 
were found across groups for all patients (P = 0.62) and for patients with depressed ejection 
fraction (P = 0.6), with a trend towards worse survival in obese patients undergoing MV 
repair (P = 0.06). Survival in obese patients undergoing repair was significantly worse than 
that in obese patients undergoing replacement (P = 0.04). 
CONCLUSIONS 
An ‘obesity paradox’ was not demonstrated after surgery for degenerative MV disease. Obese 
patients are more prone to acute kidney injury and have worse late survival after MV repair. 
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Introduction 
Obesity is an increasingly relevant medical and socioeconomic problem in developed 
countries, with well-documented impact on healthcare systems [1, 2]. The estimated costs for 
overweight and obesity was $113.9 billion in the USA in 2008, representing 4.8% of 
healthcare expenditure that year [3]. Also, obesity is known to be a strong risk factor for 
cardiovascular disease including hypertension, coronary artery disease (CAD) and heart 
failure [4, 5]. On the other hand, the relationship between body mass index (BMI) and 
outcomes following adult cardiac surgery is less clear. Obesity has been associated with 
worse clinical outcomes following open heart surgery, with higher mortality and increased 
incidence of postoperative complications including respiratory failure, prolonged intensive 
care unit stay and sternal wound infection [6–9]. Nevertheless, this relationship was not 
observed in a number of studies with several series demonstrating an ‘obesity paradox’, 
defined as an association between obesity and improved postoperative results [10–14]. The 
obesity paradox in cardiac surgery has been investigated mainly in patients undergoing 
coronary artery bypass grafting (CABG). The evidence with regard to valve surgery is 
limited, and the impact of the BMI on mitral valve (MV) surgery to the best of our 
knowledge has not been specifically analysed. Using a single-centre cohort, we conducted a 
retrospective study to clarify the relationship between the BMI and postoperative morbidity 
and mortality after isolated or combined surgery for degenerative MV disease at our 
institution. 
Materials and Methods 
The study was conducted in accordance with the principles of the Declaration of Helsinki. 
The local audit committee approved the study, and the requirement for individual patient 
consent was waived. Standard data are collected prospectively for all patients at our 
institution. The data collection form includes 5 sections that are filled in consecutively by an 
anaesthetist, a surgeon, a perfusionist and nurses; data are entered into a database (Patient 
Analysis & Tracking System, Dendrite Clinical Systems, Henley-on-Thames, UK). For this 
study, data for 1742 consecutive patients who had undergone MV surgery between April 
2000 and March 2015 were obtained from the database. After extracting patients with 
degenerative MV disease, our sample was composed of 863 consecutive patients who 
underwent isolated or combined MV surgery during the aforementioned time period. All the 
operations were performed through a vertical median sternotomy approach. 
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The logistic EuroSCORE [15] was calculated for all patients. BMI was obtained using 
Quetelet’s formula [16]. One hundred and forty-eight patients were excluded from the 
analysis because of incomplete BMI data, and therefore our final sample included 715 
patients. The study population was divided into 4 groups based on the BMI: underweight 
(<20 kg/m2), normal weight (20–24.99 kg/m2), overweight (25–29.99 kg/m2) and obese 
(>30 kg/m2). These are in close accordance with the definitions of the World Health 
Organization (WHO) excluding the underweight category, where a <20 kg/m2 cut-off was 
used instead of <18.5 kg/m2, as this has been widely used in the literature and therefore 
allowed for comparison. Early (30-day) mortality, median postoperative length of hospital 
stay, incidence of acute kidney injury (AKI), incidence of cerebrovascular accident, incidence 
of reoperation for bleeding and late survival were used as indicators of postoperative 
outcomes. The AKI was determined using pre- and postoperative serum creatinine and 
estimated glomerular filtration rate; the variable was dichotomized with a ≥2 times increase 
in creatinine or >50% decrease in estimated glomerular filtration rate, which reflects Stage 2 
AKI from the risk, injury, failure, loss, end-stage (RIFLE) criteria, defining the presence of 
AKI [17]. 
Statistical analysis 
Continuous variables are reported as mean ± standard deviation. Categorical variables are 
reported as percentage frequencies. When comparing preoperative characteristics, operative 
characteristics and postoperative outcomes across groups, the Kruskal–Wallis test was used 
for continuous variables. The χ2 comparisons were used for categorical variables, with the 
Bonferroni posthoc tests. The Fisher’s exact test was used when appropriate. P-value ≤0.05 
was taken as conferring a significant difference. Long-term survivals for each group are 
presented as the Kaplan–Meier survival curves, and the log-rank test was used to compare the 
curves. Effects of the clinical variables on long-term survival were assessed using the Cox 
proportional hazard models and are reported as hazard ratios (HRs, 95% confidence interval 
and P-value). A P-value of <0.05 was considered statistically significant. After conducting 
univariable analysis testing for main preoperative and operative variables, a multivariable 
Cox model was fitted including both the potential confounding factors and the variables that 
proved to be significantly associated with late mortality in the univariable model [age, 
gender, BMI, preoperative atrial fibrillation, history of CAD, extracardiac arteriopathy, 
hypertension, insulin-dependent diabetes mellitus, high preoperative New York Heart 
Association class, depressed left ventricular ejection fraction (LVEF), history of lung disease, 
5 
 
 
history of smoke, urgent/emergent surgery, isolated mitral procedure and mitral valve repair 
(MVr) were entered in the multivariable model]. Age and BMI were modelled as continuous 
variables using restricted cubic spline functions with 5 knots to avoid potential biases that can 
originate from categorization as previously described [18]. Associations between continuous 
predictors and long-term survival are reported as interquartile range HRs [19]. Assumption of 
proportionality was tested with the scaled Schoenfeld residuals, and it was met. 
A subanalysis was also conducted with regard to early- and long-term outcomes in patients 
with depressed LVEF, defined as <50%. 
Statistical analysis was performed with RStudio, version 1.0.136 (RStudio: Integrated 
Development for R. RStudio, Inc., Boston, MA, USA). 
Results 
Of the 715 patients in the study population, 64 (9%) were classified as underweight, 292 
(41%) as normal BMI, 263 (37%) as overweight and 96 (13%) as obese. Baseline 
characteristics are listed in Table 1. Patients in the lower BMI groups were significantly less 
likely to be male (P = 0.002). When compared with the overweight group (74% male), there 
was a significantly lower proportion of men in both the underweight (50%; P < 0.001) and 
normal weight (65%; P = 0.02) groups. Obese patients showed significantly higher rates of 
hypertension (P = 0.009) and New York Heart Association Class III/IV (P < 0.001) when 
compared with the lower BMI groups. In contrast, the proportion of patients with a history of 
smoking was significantly higher in the lower BMI groups (P < 0.001). Operative 
characteristics are listed in Table 2. Similar proportions of urgent/emergent procedures, 
reoperations and isolated MV operations were performed in each group. Cardiopulmonary 
bypass (CPB) and aortic cross-clamp (AoX) times were significantly longer in the higher 
BMI groups. The analysis of early postoperative outcomes did not demonstrate any 
statistically significant difference between groups with regard to 30-day mortality (P = 0.35), 
cerebrovascular accident (P = 0.45), reoperation for bleeding (P = 0.89) and median 
postoperative length of hospital stay (P = 0.31), as listed in Table 3. Overall incidence of AKI 
was significantly different across groups (P = 0.05), with obese patients being at increased 
risk of AKI when compared with normal BMI patients (17% vs 5.2%; P = 0.03) but not when 
compared with the other groups. 
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Early outcomes were also analysed considering patients with preoperative LVEF <50%. No 
statistically significant differences were found across BMI groups with regard to 30-day 
mortality (P = 0.93), reoperation for bleeding (P = 0.82), cerebrovascular accident (P = 0.79) 
and postoperative length of hospital stay (P = 0.23). The overall occurrence of AKI was not 
different across groups (P = 0.05), but obese patients had a significantly increased incidence 
of AKI when compared with other patients in this subgroup with depressed LVEF (42% vs 
10% in normal weight patients, P = 0.02). 
Regarding long-term survival, follow-up was 100% complete; mean follow-up was 
67 ± 44 months (range 0–190 months). The Kaplan–Meier curves were stratified according to 
the BMI groups as shown in Fig. 1. The log-rank test was conducted to compare the various 
Kaplan–Meier curves, and no statistically significant difference was found. The Kaplan–
Meier curves were also derived considering patients with depressed LVEF (Fig. 2) and 
patients who underwent MVr (Fig. 3A), and no differences in the overall long-term survival 
were found across BMI groups in these subsets of patients (P = 0.6 and P = 0.06, 
respectively). Nevertheless, a trend towards worse late survival was observed in obese 
patients undergoing MVr when compared with other BMI groups, and late survival in obese 
patients undergoing MVr was significantly worse than in obese patients undergoing mitral 
valve replacement (MVR, P = 0.04, Fig. 3B), whereas the trend within the other BMI groups 
was in favour of MVr. 
When modelled as a continuous variable, BMI was not associated with long-term mortality 
on univariable (interquartile HR 1.12; 0.75–1.67) or multivariable (interquartile HR 1.08; 
0.70–1.68) Cox analysis (Table 4, Fig. 4A and B) for long-term survival. Age, preoperative 
atrial fibrillation, CAD, hypertension, insulin-dependent diabetes mellitus, high New York 
Heart Association class, depressed LVEF, lung disease, smoke and urgency/emergency were 
found to be risk factors for late mortality on univariable analysis; age, smoke and 
preoperative atrial fibrillation remained significantly associated with late adverse outcomes in 
the multivariable model (Table 4). 
Discussion 
In this study, we analysed the outcomes of MV surgery for degenerative MV disease with 
relation to different BMI categories across 15 years at our institution. As obesity is widely 
recognized to be a risk factor for atherosclerosis, the impact of BMI on adult cardiac surgery 
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has been traditionally investigated in the context of CABG [7, 8, 20], and published series 
analysing valve surgery mainly focused on aortic valve procedures [8, 11, 13, 14, 21]. To our 
knowledge, this is the first study specifically concentrating on MV surgery. We included 
patients undergoing combined procedures, but the majority of patients had isolated MV 
surgery, and this proportion was similar across BMI groups. 
This study has 3 main findings. First, a trend towards a higher risk for postoperative AKI in 
obese patients was observed, when compared with normal weight patients; this was also 
confirmed by a subanalysis in patients with depressed LVEF. This finding has not been 
replicated by other previously published series [10, 11]. Wigfield et al. [22] found extreme 
obesity (BMI ≥ 40) to be a risk factor for postoperative AKI; in their series focused on 
valvular surgery, Thourani et al. [21] also found obese patients (BMI ≥ 36) to be at higher 
risk of postoperative AKI. Pathogenesis of AKI following cardiac surgery is multifactorial, 
and prolonged CPB and AoX times have been found to be risk factors for renal injury [23]. 
CPB and AoX times were longer in obese patients in our sample, and therefore this may 
account for our results in terms of AKI. Moreover, the higher incidence of hypertension in 
our obese group may be a marker of more advanced underlying renal disease, even though 
this was not highlighted by preoperative creatinine and estimated glomerular filtration rate 
levels. Our data indicate no clear correlation between BMI and postoperative morbidity and 
mortality other than AKI. 
Second, MV surgery can be performed with good long-term results in patients with both high 
and low BMI. Overall postoperative survival up to 10 years in our series was consistent with 
previous reports [24, 25], and it was similar across BMI groups. This was confirmed even 
after conducting survival analysis in patients with depressed LVEF and in patients who 
underwent MVr. Nevertheless, when considering the MVr subgroup, obese patients seemed 
to have a slightly worse long-term prognosis when compared with other BMI groups. 
Interestingly, we are the first group to report that long-term survival is better in obese patients 
undergoing MVR compared with MVr. This is not entirely unexpected in the challenging 
group of obese patients which can lead to longer operative times (mainly because of difficult 
access) and longer CPB and AoX times in MVr when compared with MVR. Even though the 
preoperative risk profile of these patients seemed to be homogeneous, our obese group was 
composed of 96 patients, and analyses on a larger number of individuals are needed to further 
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explain this effect. If this finding is confirmed, a technically less demanding and shorter 
MVR might be preferable in high-BMI patients. 
Third, an obesity paradox, defined as a protective effect of obesity against early postoperative 
complications and late mortality, could not be demonstrated in our study. Multiple previous 
articles reported a U- or J-shaped relationship between BMI and postoperative outcomes, 
with better results in mildly obese patients when compared with underweight and severely 
obese patients [12, 14, 26]. Several reasons have been hypothesized for this, including 
smaller coronary arteries, implantation of smaller valves and more severe CPB-related 
haemodilution in the underweight group on the one hand and more aggressive, evidence-
based medical therapy given to obese patients on the other hand [11, 27, 28]. However, 
previously published studies generally reported a higher risk profile in underweight patients 
(higher preoperative risk scores, older age and more valve procedures compared with those of 
overweight/obese patients [11, 21]), which may partially account for worse outcomes. This 
was not the case in this study: all patients underwent MV surgery, and BMI groups were 
overall well matched, with significant differences being only found in terms of gender, 
smoking history, hypertension and New York Heart Association class. In this sample of 
patients undergoing mitral surgery, we did not demonstrate a protective effect of mild obesity 
or a negative effect of low BMI on early or long-term outcomes. Regarding late survival, 
even after adjusting for confounding factors and modelling BMI as a continuous variable to 
avoid the potential bias deriving from categorization, a U- or J-shaped relationship between 
BMI and late mortality was not found. Long-term outcomes after mitral surgery have been 
investigated by Badhwar et al. [29] in a large series of patients undergoing isolated MVr: 
BMI was not related to late mortality even though obesity was found to be a risk factor for 
nonfatal outcomes including late readmission for congestive heart failure. 
In our opinion, the lack of correlation between BMI and most postoperative outcomes found 
in our series might be explained by the characteristics of the patient population included in 
this study. Our sample was mainly composed of patients with isolated MV disease, and 
associated conditions such as CAD were equally distributed across groups. Obesity is known 
to play a strong role in the pathogenesis of CAD [5] and, for this reason, an impact of BMI on 
CABG outcomes might be expected; the fact that in CABG cohorts obese patients are usually 
younger is in accordance with this prediction and indicates a more aggressive CAD. On the 
other hand, the influence of obesity on the development of MV disease is less clear and 
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probably less strong; as an indirect proof, in our sample of patients with MV disease, age was 
not significantly different across BMI groups. According to our findings, other factors such 
as AF might be more closely related to the disease process in this cluster of patients, thus 
reducing the role of BMI in determining postoperative results. 
Limitations 
The absence of data on sternal wound infection is a significant limitation of our study; sternal 
wound infection is a major complication, which has been related to BMI by other groups 
[12, 26]. Furthermore, we focused our survival analysis on the association between BMI and 
late mortality; however, BMI has been found to be related to non-fatal late adverse events, 
which we did not take into account [29]. Finally, this study is limited by its non-randomized, 
single-centre, retrospective nature; our findings must be confirmed by other surgical 
experiences, and multicentre studies are needed. 
This work was supported by the NIHR Bristol Biomedical Research Centre. 
Conflict of interest: none declared. 
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Table 1: 
Baseline patient characteristics 
Variables  Underweigh
t (n = 64)  
Normal 
weight 
(n = 292)  
Overweight 
(n = 263)  
Obese 
(n = 96)  
P-
value  
Age (years)  66.3 ± 15.7  68.6 ± 10.6  68.3 ± 10.0  66.9 ± 10.4
  
0.54  
Male, n (%)  32 (50)  189 (65)  194 (74)  63 (66)  0.002  
Hypertension, n (%)
  
25 (39)  128 (44)  132 (50)  59 (61)  0.009  
Smoking 
history, n(%)  
47 (73)  197 (67)  135 (51)  45 (47)  <0.001
  
NYHA Class III–
IV, n(%)  
27 (42)  144 (49)  128 (49)  69 (72)  <0.001
  
LVEF (%)  50.5 ± 7.4  50.3 ± 8.1  50.3 ± 8.2  50.3 ± 8.2  0.99  
Lung disease,an (%)  5 (8)  29 (10)  30 (11)  15 (16)  0.37  
Neur dysf,an (%)  2 (3)  8 (3)  3 (1)  0  0.22  
Previous MI,an (%)  2 (3)  26 (9)  27 (10)  11 (11)  0.59  
IDDM, n (%)  3 (5)  2 (1)  6 (2)  1 (1)  0.1  
Extracardiac 
arteriopathy,an (%)  
4 (6)  17 (6)  11 (4)  5 (5)  0.95  
AF, n (%)  27 (42)  111 (38)  89 (34)  35 (36)  0.74  
CAD, n (%)  11 (17)  72 (25)  88 (33)  27 (28)  0.08  
Creatinine (µmol/l)  96.5 ± 28.8  100.2 ± 23.3
  
108.9 ± 61.6
  
97.5 ± 21.4
  
0.37  
LogEuroSCORE  7.5 ± 9.1  7.0 ± 7.4  6.4 ± 6.7  6.7 ± 6.3  0.88  
P-values <0.05 reported in bold are considered statistically significant. 
a 
Defined according to the logistic EuroSCORE model. 
AF: atrial fibrillation; CAD: coronary artery disease; IDDM: insulin-dependent diabetes 
mellitus; LVEF: left ventricular ejection fraction; MI: myocardial infarction; Neur dysf: 
neurological dysfunction; NYHA: New York Heart Association. 
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Table 2: 
Operative characteristics 
Variables  Underweigh
t (n = 64)  
Normal 
weight 
(n = 292)
  
Overweigh
t (n = 263)  
Obese 
(n = 96)  
P-
value  
Urgency/emergency, n (%
)  
15 (23)  69 (24)  61 (23)  20 (21)  0.95  
Redo surgery, n (%)  5 (8)  21 (7)  22 (8)  11 (11)  0.62  
CPB time (min)  110 ± 33  123 ± 51  137 ± 58  136 ± 53
  
<0.001
  
AoX time (min)  77 ± 28  87 ± 35  92 ± 35  95 ± 35  <0.001
  
Isolated mitral 
surgery, n (%)  
53 (83)  223 (76)  184 (70)  73 (76)  0.11  
P-values <0.05 reported in bold are considered statistically significant. 
AoX: aortic cross-clamp; CPB: cardiopulmonary bypass. 
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Table 3: 
Early postoperative outcomes 
Variables  Underweight 
(n = 64)  
Normal 
weight 
(n = 292)  
Overweight 
(n = 263)  
Obese 
(n = 96)  
P-
value  
30-day 
mortality, n(%)  
2 (3)  9 (3)  16 (6)  4 (4)  0.35  
CVA, n (%)  1 (2)  9 (3)  3 (1)  2 (2)  0.45  
AKI,an (%)  2 (7)a  9 (5)a  12 (9)a  9 (17)a  0.06  
Reoperation for 
bleeding, n (%)  
3 (5)  16 (5)  11 (4)  4 (4)  0.9  
LOS (days), 
median (IQR)  
8 (6–12)  8 (6–12)  9 (6–13)  9 (7–14)  0.31  
a 
Because information on kidney function prior to February 2009 was not available, data for 
AKI were calculated on 393 patients. 
AKI: acute kidney injury; CVA: cerebrovascular accident; IQR: interquartile range; LOS: 
length of hospital stay. 
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Table 4: 
Univariable and multivariable Cox model analyses for overall survival 
Variables  Univariable 
 
  
Multivariable 
 
  
HR  95% CI  P-
value  
HR  95% CI  P-
value  
Age  3.25  2.09–
5.04  
<0.001  3.23  1.98–
5.29  
<0.001  
BMI  1.12  0.75–
1.67  
0.8  1.04  0.67–
1.61  
0.84  
Male sex  0.79  0.58–
1.07  
0.13  0.78  0.54–
1.13  
0.2  
Hypertension  1.41  1.04–
1.89  
0.02  0.80  0.57–
1.14  
0.22  
Smoking history  1.54  1.14–
2.07  
0.005  1.47  1.04–
2.06  
0.03  
AF  2.12  1.58–
2.85  
<0.001  1.90  1.34–
2.69  
0.003  
NYHA Class III–IV  1.71  1.26–
2.32  
0.006  1.08  0.76–
1.54  
0.67  
LVEF <50%  1.95  1.45–
2.63  
<0.001  1.32  0.91–
1.90  
0.14  
CAD  1.44  1.06–
1.95  
0.02  1.16  0.71–
1.90  
0.55  
Lung disease  1.64  1.06–
2.53  
0.02  1.24  0.75–
2.06  
0.40  
IDDM  2.29  1.07–
4.90  
0.03  1.89  0.85–
4.18  
0.12  
Extracardiac 
arteriopathy  
1.74  0.99–
3.06  
0.06  1.70  0.89–
3.24  
0.11  
Isolated mitral  0.78  0.57–
1.07  
0.12  1.34  0.83–
2.16  
0.23  
Repair  1.079  0.78–
1.49  
0.64  1.14  0.77–
1.68  
0.50  
Urgency/emergency  1.75  1.29–
2.39  
0.004  1.42  0.97–
2.10  
0.07  
P-values <0.05 reported in bold are considered statistically significant. 
AF: atrial fibrillation; BMI: body mass index; CAD: coronary artery disease; CI: confidence 
interval; HR: hazard ratio; IDDM: insulin-dependent diabetes mellitus; LVEF: left ventricular 
ejection fraction; MI: myocardial infarction; NYHA: New York Heart Association. 
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Figure Legend 
Figure 1. The Kaplan–Meier curves stratified for BMI groups for overall population. BMI: 
body mass index. 
Figure 2. The Kaplan–Meier curves stratified for BMI groups in patients with depressed 
ejection fraction. BMI: body mass index. 
Figure 3. (A) The Kaplan–Meier curves stratified for BMI groups in patients undergoing 
mitral valve repair. (B) The Kaplan–Meier curves for obese patients undergoing mitral valve 
replacement and mitral valve repair. BMI: body mass index. 
Figure 4. The relationship between BMI-restricted cubic spline function and hazard ratio for 
late mortality on unadjusted univariable (A) and adjusted multivariable (B) analyses. BMI: 
body mass index. 
 
 
